Structural basis for the regulation of enzymatic activity of Regnase-1 by domain-domain interactions by Yokogawa, Mariko et al.
Title Structural basis for the regulation of enzymatic activity ofRegnase-1 by domain-domain interactions
Author(s)
Yokogawa, Mariko; Tsushima, Takashi; Noda, Nobuo N.;
Kumeta, Hiroyuki; Enokizono, Yoshiaki; Yamashita, Kazuo;
Standley, Daron M.; Takeuchi, Osamu; Akira, Shizuo; Inagaki,
Fuyuhiko




This work is licensed under a Creative Commons Attribution
4.0 International License. The images or other third party
material in this article are included in the article's Creative
Commons license, unless indicated otherwise in the credit line;
if the material is not included under the Creative Commons
license, users will need to obtain permission from the license





1Scientific RepoRts | 6:22324 | DOI: 10.1038/srep22324
www.nature.com/scientificreports
Structural basis for the regulation 
of enzymatic activity of Regnase-1 
by domain-domain interactions
Mariko Yokogawa1, Takashi Tsushima2, Nobuo N. Noda3, Hiroyuki Kumeta1, 
Yoshiaki Enokizono1, Kazuo Yamashita4, Daron M. Standley4,6, Osamu Takeuchi4,5,6, 
Shizuo Akira4,5 & Fuyuhiko Inagaki1
Regnase-1 is an RNase that directly cleaves mRNAs of inflammatory genes such as IL-6 and IL-12p40, 
and negatively regulates cellular inflammatory responses. Here, we report the structures of four 
domains of Regnase-1 from Mus musculus—the N-terminal domain (NTD), PilT N-terminus like (PIN) 
domain, zinc finger (ZF) domain and C-terminal domain (CTD). The PIN domain harbors the RNase 
catalytic center; however, it is insufficient for enzymatic activity. We found that the NTD associates 
with the PIN domain and significantly enhances its RNase activity. The PIN domain forms a head-to-tail 
oligomer and the dimer interface overlaps with the NTD binding site. Interestingly, mutations blocking 
PIN oligomerization had no RNase activity, indicating that both oligomerization and NTD binding 
are crucial for RNase activity in vitro. These results suggest that Regnase-1 RNase activity is tightly 
controlled by both intramolecular (NTD-PIN) and intermolecular (PIN-PIN) interactions.
The initial sensing of infection is mediated by a set of pattern-recognition receptors (PRRs) such Toll-like recep-
tors (TLRs) and the intracellular signaling cascades triggered by TLRs evoke transcriptional expression of inflam-
matory mediators that coordinate the elimination of pathogens and infected cells1–3. Since aberrant activation of 
this system leads to auto immune disorders, it must be tightly regulated. Regnase-1 (also known as Zc3h12a and 
MCPIP1) is an RNase whose expression level is stimulated by lipopolysaccharides and prevents autoimmune 
diseases by directly controlling the stability of mRNAs of inflammatory genes such as interleukin (IL)-6, IL-1β , 
IL-2, and IL-12p404–7. Regnase-1 accelerates target mRNA degradation via their 3′ -terminal untranslated region 
(3′ UTR), and also degrades its own mRNA8.
Regnase-1 is a member of Regnase family and is composed of a PilT N-terminus like (PIN) domain followed 
by a CCCH-type zinc–finger (ZF) domain, which are conserved among Regnase family members7,9,10. Recently, 
the crystal structure of the Regnase-1 PIN domain derived from Homo sapiens was reported11. The structure com-
bined with functional analyses revealed that four catalytically important Asp residues form the catalytic center 
and stabilize Mg2+ binding that is crucial for RNase activity. Several CCCH-type ZF motifs in RNA-binding 
proteins have been reported to directly bind RNA12–15. In addition, Regnase-1 has been predicted to possess 
other domains in the N- and C- terminal regions16,17. However, the structure and function of the ZF domain, 
N-terminal domain (NTD) and C-terminal domain (CTD) of Regnase-1 have not been solved.
Here, we performed structural and functional analyses of individual domains of Regnase-1 derived from 
Mus musculus in order to understand the catalytic activity in vitro. Our data revealed that the catalytic activity 
of Regnase-1 is regulated through both intra and intermolecular domain interactions in vitro. The NTD plays 
a crucial role in efficient cleavage of target mRNA, through intramolecular NTD-PIN interactions. Moreover, 
Regnase-1 functions as a dimer through intermolecular PIN-PIN interactions during cleavage of target mRNA. 
Our findings suggest that Regnase-1 cleaves its target mRNA by an NTD-activated functional PIN dimer, while 
the ZF increases RNA affinity in the vicinity of the PIN dimer.
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Results
Domain structures of Regnase-1. We analyzed Rengase-1 derived from Mus musculus and solved 
the structures of the four domains; NTD, PIN, ZF, and CTD individually by X-ray crystallography or NMR 
(Fig. 1a–e). X-ray crystallography was attempted for the fragment containing both the PIN and ZF domains, 
however, electron density was observed only for the PIN domain (Fig. 1c), consistent with a previous report 
on Regnase-1 derived from Homo sapiens11. This suggests that the PIN and ZF domains exist independently 
without interacting with each other. The domain structures of NTD, ZF, and CTD were determined by NMR 
(Fig. 1b,d,e). The NTD and CTD are both composed of three α helices, and structurally resemble ubiquitin conju-
gating enzyme E2 K (PDB ID: 3K9O) and ubiquitin associated protein 1 (PDB ID: 4AE4), respectively, according 
to the Dali server18.
Contribution of each domain of Regnase-1 to the mRNA binding activity. Although the PIN 
domain is responsible for the catalytic activity of Regnase-14, the roles of the other domains are largely unknown. 
First, we evaluated a role of the NTD and ZF domains for mRNA binding by an in vitro gel shift assay (Fig. 1f). 
Fluorescently 5′ -labeled RNA corresponding to nucleotides 82–106 of the IL-6 mRNA 3′ UTR and the catalyt-
ically inactive mutant (D226N and D244N) of Regnase-1—hereafter referred to as the DDNN mutant—were 
utilized. Upon addition of a larger amount of Regnase-1, the fluorescence of free RNA decreased, indicating that 
Regnase-1 bound to the RNA. Based on the decrease in the free RNA fluorescence band, we evaluated the contri-
bution of each domain of Regnase-1 to RNA binding. While the RNA binding ability was not significantly changed 
in the presence of NTD, it increased in the presence of the ZF domain (Fig. 1f,g and Supplementary Fig. 1). 
Direct binding of the ZF domain and RNA were confirmed by NMR spectral changes. The fitting of the titration 
curve of Y314 resulted in an apparent dissociation constant (Kd) of 10 ± 1.1 μM (Supplementary Fig. 2). These 
results indicate that not only the PIN but also the ZF domain contribute to RNA binding, while the NTD is not 
likely to be involved in direct interaction with RNA.
Figure 1. Structural and functional analyses of Regnase-1. (a) Domain architecture of Regnase-1. (b) 
Solution structure of the NTD. (c) Crystal structure of the PIN domain. Catalytic Asp residues were shown in 
sticks. (d) Solution structure of the ZF domain. Three Cys residues and one His residue responsible for Zn2+-
binding were shown in sticks. (e) Solution structure of the CTD. All the structures were colored in rainbow 
from N-terminus (blue) to C-terminus (red). (f) In vitro gel shift binding assay between Regnase-1 and IL-6 
mRNA. Fluorescence intensity of the free IL-6 in each sample was indicated as the percentage against that in 
the absence of Regnase-1. (g) Binding of Regnase-1 and IL-6 mRNA was plotted. The percentage of the bound 
IL-6 was calculated based on the fluorescence intensities of the free IL-6 quantified in (f). (h) In vitro cleavage 
assay of Regnase-1 to IL-6 mRNA. Fluorescence intensity of the uncleaved IL-6 mRNA was indicated as the 
percentage against that in the absence of Regnase-1.
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Contribution of each domain of Regnase-1 to RNase activity. In order to characterize the role of 
each domain in the RNase activity of Regnase-1, we performed an in vitro cleavage assay using fluorescently 
5′ -labeled RNA corresponding to nucleotides 82–106 of the IL-6 mRNA 3′ UTR (Fig. 1g). Regnase-1 constructs 
consisting of NTD-PIN-ZF completely cleaved the target mRNA and generated the cleaved products. The appar-
ent half-life (T1/2) of the RNase activity was about 20 minutes. Regnase-1 lacking the ZF domain generated a 
smaller but appreciable amount of cleaved product (T1/2 ~ 70 minutes), while those lacking the NTD did not gen-
erate cleaved products (T1/2 > 90 minutes). It should be noted that NTD-PIN(DDNN)-ZF, which possesses the 
NTD but lacks the catalytic residues in PIN, completely lost all RNase activity (Fig. 1g, right panel), as expected, 
confirming that the RNase catalytic center is located in the PIN domain. Taken together with the results in the 
previous section, we conclude that the NTD is crucial for the RNase activity of Regnase-1 in vitro, although it does 
not contribute to the direct mRNA binding.
Dimer formation of the PIN domains. During purification by gel filtration, the PIN domain exhibited 
extremely asymmetric elution peaks in a concentration dependent manner (Fig. 2a). By comparison with the 
elution volume of standard marker proteins, the PIN domain was assumed to be in equilibrium between a mon-
omer and a dimer in solution at concentrations in the 20–200 μM range. The crystal structure of the PIN domain 
has been determined in three distinct crystal forms with a space group of P3121 (form I in this study and PDB 
ID 3V33), P3221 (form II in this study), and P41 (PDB ID 3V32 and 3V34), respectively11. We found that the PIN 
domain formed a head-to-tail oligomer that was commonly observed in all three crystal forms in spite of the dif-
ferent crystallization conditions (Supplementary Fig. 3). Mutation of Arg215, whose side chain faces to the oppo-
site side of the oligomeric surface, to Glu preserved the monomer/dimer equilibrium, similar to the wild type. 
On the other hand, single mutations of side chains involved in the PIN–PIN oligomeric interaction resulted in 
monomer formation, judging from gel filtration (Fig. 2a,b). Wild type and monomeric PIN mutants (P212A and 
D278R) were also analyzed by NMR. The spectra indicate that the dimer interface of the wild type PIN domain 
were significantly broadened compared to the monomeric mutants (Supplementary Fig. 4). These results indicate 
that the PIN domain forms a head-to-tail oligomer in solution similar to the crystal structure. Interestingly, the 
monomeric PIN mutants P212A, R214A, and D278R had no significant RNase activity for IL-6 mRNA in vitro 
(Fig. 2c). The side chains of these residues point away from the catalytic center on the same molecule (Fig. 2b). 
Therefore, we concluded that head-to-tail PIN dimerization, together with the NTD, are required for Regnase-1 
RNase activity in vitro.
Domain-domain interaction between the NTD and the PIN domain. While the NTD does not 
contribute to RNA binding (Fig. 1f,g, and Supplementary Fig. 1), it increases the RNase activity of Regnase-1 
(Fig. 1h). In order to gain insight into the molecular mechanism of the NTD-mediated enhancement of Regnase-1 
RNase activity, we further investigated the domain-domain interaction between the NTD and the PIN domain 
Figure 2. Head-to-tail oligomer formation of the PIN domain is crucial for the RNase activity of 
Regnase-1. (a) Gel filtration analyses of the PIN domain. Elution volumes of the standard marker proteins 
were indicated by arrows at the upper part. (b) Dimer structure of the PIN domain. Two PIN molecules in 
the crystal were colored white and green, respectively. Catalytic residues and mutated residues were shown in 
sticks. Residues important for the oligomeric interaction were colored red, while R215 that was dispensable 
for the oligomeric interaction was colored blue. (c) RNase activity of monomeric mutants for IL-6 mRNA was 
analyzed.
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using NMR. We used the catalytically inactive monomeric PIN mutant possessing both the DDNN and D278R 
mutations to avoid dimer formation of the PIN domain. The NMR signals from the PIN domain (residues V177, 
F210-T211, R214, F228-L232, and F234-S236) exhibited significant chemical shift changes upon addition of 
the NTD (Fig. 3a). Likewise, upon addition of the PIN domain, NMR signals derived from R56, L58-G59, and 
V86-H88 in the NTD exhibited large chemical shift changes and residues D53, F55, K57, Y60-S61, V68, T80-G83, 
L85, and G89 of the NTD as well as side chain amide signals of N79 exhibited small but appreciable chemical shift 
changes (Fig. 3b and Supplementary Fig. 5). These results clearly indicate a direct interaction between the PIN 
domain and the NTD. Based on the titration curve for the chemical shift changes of L58, the apparent Kd between 
the isolated NTD and PIN was estimated to be 110 ± 5.8 μM. Considering the fact that the NTD and PIN domains 
Figure 3. Domain-domain interaction between the NTD and the PIN domain. (a) NMR analyses of the 
NTD-binding to the PIN domain. The residues with significant chemical shift changes were labeled in the 
overlaid spectra (left) and colored red on the surface and ribbon structure of the PIN domain (right). Pro and 
the residues without analysis were colored black and gray, respectively. (b) NMR analyses of the PIN-binding 
to the NTD. The residues with significant chemical shift changes were labeled in the overlaid spectra (left) and 
colored red, yellow, or green on the surface and ribbon structure of the NTD. S62 was colored gray and excluded 
from the analysis, due to low signal intensity. (c) Docking model of the NTD and the PIN domain. The NTD 
and the PIN domain are shown in cyan and white, respectively. Residues in close proximity (< 5 Å) to each other 
in the docking structure were colored yellow. Catalytic residues of the PIN domain are shown in sticks, and the 
residues that exhibited significant chemical shift changes in (a,b) were labeled.
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are attached by a linker, the actual binding affinity is expected much higher in the native protein. Mapping the 
residues with chemical shift changes reveals the putative PIN/NTD interface, which includes a helix that harbors 
catalytic residues D225 and D226 on the PIN domain (Fig. 3a). Interestingly, the putative binding site for the 
NTD overlaps with the PIN-PIN dimer interface, implying that NTD binding can “terminate” PIN-PIN oligomer-
ization (Fig. 2b). An in silico docking of the NTD and PIN domains using chemical shift restraints provided a 
model consistent with the NMR experiments (Fig. 3c).
Residues critical for Regnase-1 RNase activity. To gain insight into the residues critical for Regnase-1 
RNase activity, each basic or aromatic residue located around the catalytic site of the PIN oligomer was mutated 
to alanine, and the oligomerization and RNase activity were investigated (Fig. 4). From the gel filtration assays, all 
mutants except R214A formed dimers, suggesting that any lack of RNase activity in the mutants, except R214A, 
was directly due to mutational effects of the specific residues and not to abrogation of dimer formation. The 
W182A, R183A, and R214A mutants markedly lost cleavage activity for IL-6 mRNA as well as for Regnase-1 
mRNA. The K184A, R215A, and R220A mutants moderately but significantly decreased the cleavage activity 
for both target mRNAs. The importance of K219 and R247 was slightly different for IL-6 and Regnase-1 mRNA; 
both K219 and R247 were more important in the cleavage of IL-6 mRNA than for Regnase-1 mRNA. The other 
mutated residues—K152, R158, R188, R200, K204, K206, K257, and R258—were not critical for RNase activity. 
The importance of residues W182 and R183 can readily be understood in terms of the monomeric PIN structure 
as they are located near to the RNase catalytic site; however, the importance of residue K184, which points away 
from the active site is more easily rationalized in terms of the oligomeric structure, in which the “secondary” 
chain’s residue K184 is positioned near the “primary” chain’s catalytic site (Fig. 4). In contrast, R214 is important 
for oligomerization of the PIN domain and the “secondary” chain’s residue R214 is also positioned near the “pri-
mary” chain’s active site within the dimer interface. It should be noted that the putative-RNA binding residues 
K184 and R214 are unique to Regnase-1 among PIN domains.
Molecular mechanism of target mRNA cleavage by the PIN dimer. Our mutational experiments 
indicated that the observed dimer is functional and that the role of the secondary PIN domain is to position 
Regnase-1-unique RNA binding residues near the active site of the primary PIN domain. If this model is correct, 
then we reasoned that a catalytically inactive PIN and a PIN lacking the putative RNA-binding residues ought to 
be inactive in isolation but become active when mixed together. In order to test this hypothesis, we performed 
in vitro cleavage assays using combinations of Regnase-1 mutants that had no or decreased RNase activities by 
Figure 4. Critical residues in the PIN domain for the RNase activity of Regnase-1. (a) In vitro cleavage assay 
of basic residue mutants for IL-6 mRNA. The results indicate mean ± SD of four independent experiments. 
(b) In vitro cleavage assay of basic residue mutants for Regnase-1 mRNA. The results indicate mean ± SD of 
three independent experiments. The fluorescence intensity of the uncleaved mRNA was quantified and the 
results were mapped on the PIN dimer structure. Mutated basic residues were shown in sticks and those with 
significantly reduced RNase activities were colored red or yellow.
www.nature.com/scientificreports/
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themselves (Fig. 5). One group consisted of catalytically active PIN domains with mutation of basic residues 
found in the previous section to confer decreased RNase activity (Fig. 4). These were paired with a DDNN mutant 
that had no RNase activity by itself. When any members of the two groups are mixed, two kinds of heterodimers 
can be formed: one is composed of a DDNN primary PIN and a basic residue mutant secondary PIN and is 
expected to exhibit no RNase activity; the other is composed of a basic residue mutant primary PIN and a DDNN 
secondary PIN and is predicted to rescue RNase activity (Fig. 5a). When we compared the fluorescence intensity 
of uncleaved IL-6 mRNA, basic residue mutants W182A, K184A, R214A, and R220A were rescued upon addi-
tion of the DDNN mutant (Fig. 5b). Consistently, when we compared the fluorescence intensity of the uncleaved 
Regnase-1 mRNA, basic residue mutants K184A and R214A were rescued upon addition of the DDNN mutant 
(Fig. 5c). Rescue of K184A and R214A by the DDNN mutant was also confirmed by a significant increase in the 
cleaved products. This is particularly significant because the side chains of K184 and R214 in the primary PIN are 
oriented away from their own catalytic center, while those in the secondary PIN face toward the catalytic center 
of the primary PIN. R214 is an important residue for dimer formation as shown in Fig. 2, therefore, R214A in 
the secondary PIN cannot dimerize. According to the proposed model, an R214A PIN domain can only form a 
dimer when the DDNN PIN acts as the secondary PIN. Taken together, the rescue experiments above support the 
proposed model in which the head-to-tail dimer is functional in vitro.
Figure 5. Heterodimer formation by combination of the Regnase-1 basic residue mutants and the DDNN 
mutant restored the RNase activity. (a) Cartoon representation of the concept of the experiment. (b) In vitro 
cleavage assay of Regnase-1 for IL-6 mRNA. (c) In vitro cleavage assay of Regnase-1 for Regnase-1 mRNA. 
The results indicate mean ± SD of three independent experiments. The fluorescence intensity of the uncleaved 
mRNA was quantified and the results were mapped on the PIN dimer. The mutations whose RNase activities 
were not increased in the presence of DDNN mutant were colored in blue on the primary PIN. The mutations 
whose RNase activities were restored in the presence of DDNN mutant were colored in red or yellow on the 
primary PIN.
www.nature.com/scientificreports/
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Discussion
We determined the individual domain structures of Regnase-1 by NMR and X-ray crystallography. Although the 
function of the CTD remains elusive, we revealed the functions of the NTD, PIN, and ZF domains. A Regnase-1 
construct consisting of PIN and ZF domains derived from Mus musculus was crystallized; however, the electron 
density of the ZF domain was low, indicating that the ZF domain is highly mobile in the absence of target mRNA 
or possibly other protein-protein interactions. Our NMR experiments confirmed direct binding of the ZF domain 
to IL-6 mRNA with a Kd of 10 ± 1.1 μM. Furthermore, an in vitro gel shift assay indicated that Regnase-1 con-
taining the ZF domain enhanced target mRNA-binding, but the protein-RNA complex remained in the bottom 
of the well without entering into the polyacrylamide gel. These results indicate that Regnase-1 directly binds to 
RNA and precipitates under such experimental conditions. Due to this limitation, it is difficult to perform further 
structural analyses of mRNA-Regnase-1 complexes by X-ray crystallography or NMR.
The previously reported crystal structure of the Regnase-1 PIN domain derived from Homo sapiens is nearly 
identical to the one derived from Mus musculus in this study, with a backbone RMSD of 0.2 Å. The amino acid 
sequences corresponding to PIN (residues 134–295) are the two non-identical residues are substituted with sim-
ilar amino acids. Both the mouse and human PIN domains form head-to-tail oligomers in three distinct crystal 
forms. Rao and co-workers previously argued that PIN dimerization is likely to be a crystallographic artifact 
with no physiological significance, since monomers were dominant in their analytical ultra-centrifugation exper-
iments11. In contrast, our gel filtration data, mutational analyses, and NMR spectra all indicate that the PIN 
domain forms a head-to-tail dimer in solution in a manner similar to the crystal structure. This inconsistency 
might be due to difference in the analytical methods and/or protein concentrations used in each experiment, 
since the oligomer formation of PIN was dependent on the protein concentration in our study.
Single mutations to residues involved in the putative oligomeric interaction of PIN monomerized as expected 
and these mutants lost their RNase activity as well. Since the NMR spectra of monomeric mutants overlaps with 
those of the oligomeric forms, it is unlikely that the tertiary structure of the monomeric mutants were affected 
by the mutations. (Supplementary Fig. 4b,c). Based on these observations, we concluded that PIN-PIN dimer 
formation is critical for Regnase-1 RNase activity in vitro. Within the crystal structure of the PIN dimer, the 
Regnase-1 specific basic regions in both the “primary” and “secondary” PINs are located around the catalytic site 
of the primary PIN (Supplementary Fig. 6). Moreover, our structure-based mutational analyses showed these two 
Regnase-1 specific basic regions were essential for target mRNA cleavage in vitro.
The cleavage assay also showed that the NTD is crucial for efficient mRNA cleavage. Moreover, we found that 
the NTD associates with the oligomeric surface of the primary PIN, docking to a helix that harbors its catalytic 
residues (Figs 2b and 3a). Taken together, this suggests that the NTD and the PIN domain compete for a common 
binding site. The affinity of the domain-domain interaction between two PIN domains (Kd = ~10−4 M) is similar 
to that of the NTD-PIN (Kd = 110 ± 5.8 μM) interactions; however, the covalent connection corresponding to 
residues 90–133 between the NTD and the primary PIN will greatly enhance the intramolecular domain interac-
tion in the case of full-length Regnase-1. While further analyses are necessary to prove this point, our preliminary 
docking and molecular dynamics simulations indicate that NTD-binding rearranges the catalytic residues of the 
PIN domain toward an active conformation suitable for binding Mg2+. In this context, it is interesting that, in 
response to TCR stimulation, Malt1 cleaves Regnase-1 at R111 to control immune responses in vivo19. This result 
is consistent with a model in which the NTD acts as an enhancer, and cleavage of the linker lowers enzymatic 
activity dramatically.
Based on these structural and functional analyses of Regnase-1 domain-domain interactions, we performed 
docking simulations of the NTD, PIN dimer, and IL-6 mRNA. We incorporated information from the cleav-
age site of IL-6 mRNA in vitro is indicated by denaturing polyacrylamide gel electrophoresis (Supplementary 
Fig. 7a,b). The docking result revealed multiple RNA binding modes that satisfied the experimental results 
in vitro (Supplementary Fig. 7c,d), however, it should be noted that, in vivo, there would likely be many other 
RNA-binding proteins that would protect loop regions from cleavage by Regnase-1.
The overall model of regulation of Regnase-1 RNase activity through domain-domain interactions in vitro is 
summarized in Fig. 6. In the absence of target mRNA, the PIN domain forms head-to-tail oligomers at high con-
centration. A fully active catalytic center can be formed only when the NTD associates with the oligomer surface 
of the PIN domain, which terminates the head-to-tail oligomer formation in one direction (primary PIN), and 
forms a functional dimer together with the neighboring PIN (secondary PIN). While further investigations on 
the domain-domain interactions of Regnase-1 in vivo are necessary, these intramolecular and intermolecular 
domain interactions of Regnase-1 appear to structurally constrain Regnase-1activity, which, in turn, enables tight 
regulation of immune responses.
Methods
Protein expression and purification. The DNA fragment encoding Regnase-1 derived from Mus muscu-
lus was cloned into pGEX6p vector (GE Healthcare). All the mutants were generated by PCR-mediated site-di-
rected mutagenesis and confirmed by the DNA sequence analyses. As a catalytically deficient mutant, both 
Asp226 and Asp244 at the catalytic center of PIN were mutated to Asn, which is referred to as DDNN mutant. 
Regnase-1 was expressed at 16 °C using the Escherichia coli RosettaTM(DE3)pLysS strain. After purification with 
a GST-affinity resin, an N-terminal GST tag was digested by HRV-3 C protease. NTD was further purified by gel 
filtration chromatography using a HiLoad 16/60 Superdex 75 pg (GE Healthcare). The other domains were further 
purified by cation exchange chromatography using Resource S (GE Healthcare), followed by gel filtration chroma-
tography using a HiLoad 16/60 Superdex 75 pg (GE Healthcare). Uniformly 15N or 13C, 15N-double labeled pro-
teins for NMR experiments were prepared by growing E. coli host in M9 minimal medium containing 15NH4Cl, 
unlabeled glucose and 15N CELTONE® Base Powder (CIL) or 15NH4Cl, 13C6-glucose, and13C, 15N CELTONE® 
Base Powder (CIL), respectively.
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X-ray crystallography. Crystallization was performed using the sitting drop vapor diffusion method at 
20 °C and two crystal forms (I and II) were obtained. In the case of form I crystals, drops (0.5 μl) of 6 mg/ml 
selenomethionine-labeled Regnase-1 PIN-ZF (residues 134–339 derived from Mus musculus) in 20 mM 
HEPES-NaOH (pH 6.8), 200 mM NaCl and 5 mM DTT were mixed with reservoir solution consisting of 1 M 
(NH4)2HPO4, 200 mM NaCl and 100 mM sodium citrate (pH 5.5) whereas in the case of form II crystals, drops 
(0.5 μl) of 6 mg/ml native Regnase-1 PIN-ZF (residues 134–339) in 20 mM HEPES-NaOH (pH 6.8), 200 mM 
NaCl and 5 mM DTT were mixed with reservoir solution consisting of 1.7 M NaCl and 100 mM HEPES-NaOH 
(pH 7.0). Diffraction data were collected at a Photon Factory Advanced Ring beamline NE3A (form I) or at a 
SPring-8 beamline BL41XU (form II), and were processed with HKL200020. The structure of the form I crystal 
was determined by the multiple anomalous dispersion (MAD) method. Nine Se sites were found using the pro-
gram SOLVE21; however, the electron density obtained by MAD phases calculated using SOLVE was not good 
enough to build a model even after density modification using the program RESOLVE22. Then the program CNS23 
was used to find additional three Se sites and calculate MAD phases using 12 Se sites. The electron density after 
density modification using CNS was good enough to build a model. Structure of the form II crystal was deter-
mined by the molecular replacement method using CNS and using the structure of the form I crystal as a search 
model. For all structures, further model building was performed manually with COOT24, and TLS and restrained 
refinement using isotropic individual B factors was performed with REFMAC525 in the CCP4 program suite26. 
Crystallographic parameters are summarized in Supplementary Table 1.
NMR measurements. All NMR experiments were carried out at 298 K on Inova 500-MHz, 600-MHz, and 
800-MHz spectrometer (Agilent). The NMR data were processed using the NMRPipe27, the Olivia (fermi.pharm.
hokudai.ac.jp/olivia/), and the Sparky program (Sparky3, University of California, San Francisco).
For structure calculation, NOE distance restraints were obtained from 3D 15N-NOESY-HSQC (100 ms mixing 
time for the NTD, 75 ms mixing time for the ZF domain and the CTD) and 13C-NOESY-HSQC spectra (100 ms 
mixing time for the NTD, 75 ms mixing time for the ZF domain and the CTD). The NMR structures were deter-
mined using the CANDID/CYANA2.128. Dihedral restraints were derived from backbone chemical shifts using 
TALOS29.
For the domain-domain interaction analyses between the NTD and the PIN domain, 1H-15N HSQC spectra 
of uniformly 15N-labeled proteins in the concentration of 100 μM were obtained in the presence of 3 or 6 molar 
equivalents of unlabeled proteins.
Preparation of RNAs. The fluorescently labeled RNAs at the 5′ -end by 6-FAM were purchased from 
SIGMA-ALDORICH. The RNA sequences used in this study were shown below.
IL-6 mRNA 3′ UTR (82–106): 5′ -UGUUGUUCUCUACGAAGAACUGACA-3′ (25 nts)
Regnase-1 mRNA 3′ UTR (191–211): 5′ - CUGUUGAUACACAUUGUAUCU-3′ (21 nts)
Electrophoretic mobility shift assay. Catalytically deficient Regnase-1 proteins, containing DDNN 
mutations, and 5′ -terminally 6-FAM labeled RNAs were incubated in the RNA-binding buffer (20 mM 
HEPES-NaOH (pH 6.8), 150 mM NaCl, 1 mM DTT, 10% glycerol (v/v), and 0.1% NP-40 (v/v)) at 4 °C for 
Figure 6. Schematic representation of regulation of the Regnase-1 catalytic activity through the domain-
domain interactions. 
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30 minutes, then analyzed by non-denaturing polyacrylamide gel electrophoresis. The electrophoreses were per-
formed at 4 °C using the 7.5% polyacrylamide (w/v) gel (monomer : bis = 29 : 1) in the electrophoresis buffer 
(25 mM Tris-HCl (pH 7.5) and 200 mM glycine). The fluorescence of 6-FAM labeled RNA was directly detected 
at the excitation wavelength of 460 nm with a fluorescence filter (Y515-Di) using a fluoroimaging analyzer (LAS-
4000 (FUJIFILM)). The fluorescence intensity of each sample was quantified using ImageJ software.
In vitro RNA cleavage assay. Regnase-1 (2 μM) and 5′ -terminally 6-FAM labeled RNA (1 μM) were incu-
bated in the RNA-cleavage buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl2, and 1 mM DTT) at 
37 °C. For the assay using combinations of Regnase-1 mutants, equimolar amounts of Regnase-1 mutants (2 μM 
each) were mixed with fluorescently labeled RNA (1 μM). After incubation for 30–120 minutes, the reaction was 
stopped by the addition of 1.5-fold volume of denaturing buffer containing 8 M urea and 100 mM EDTA, and 
samples were boiled. The electrophoreses were performed at room temperature using the 8 M urea containing 
denaturing gel with 20% polyacrylamide (w/v) (monomer : bis = 19 : 1) in 0.5 × TBE as the electrophoresis buffer.
Docking calculations. For docking NTD to PIN, OSCAR-star30 was first used to rebuild sidechains in the 
head-to-tail PIN dimer. Docking was carried out by surFit (http://sysimm.ifrec.osaka-u.ac.jp/docking/main/) 
with restraints obtained from NMR data (Fig. 3a,b) as follows. NTD: R56, L58, G59, V86, K87, H88; PIN: V177, 
F210, T211, R214, F228, I229, V230, K231, L232, F234, D235, S236. Top-scoring model was selected.
For docking IL-6 mRNA 3′ UTR to the PIN dimer, each domain of the PIN dimer structure was superimposed 
onto the PIN dimer of the human X-ray structure (PDB ID: 3V34) in order to graft both water molecules and 
Mg2+ ions to the mouse model. Each IL-6 representative structure was submitted to the HADDOCK 2.0 server, 
for total of 10 independent jobs. In order to be consistent with the cleavage assay, active residues consisted of 
all nucleotides in RNA, Mg2+ and W182, R183, K184, R188, R214, R215, K219, R220, and R247 in the protein. 
Docked models were selected based on the following criteria: one heavy atom within 7, 8, or 9th nucleotide from 
the 5′ end was < 5 Å from the Mg2+ ion on the primary PIN. Further classification was done manually in order to 
divide the selected models into two clusters.
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